Logo image of PMI

PICARD MEDICAL INC (PMI) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:PMI - US71953R1086 - Common Stock

2.13 USD
+0.04 (+1.91%)
Last: 11/28/2025, 7:55:19 PM
2.11 USD
-0.02 (-0.94%)
After Hours: 11/28/2025, 7:55:19 PM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to PMI. PMI was compared to 188 industry peers in the Health Care Equipment & Supplies industry. PMI has a bad profitability rating. Also its financial health evaluation is rather negative. PMI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PMI has reported negative net income.
PMI Yearly Net Income VS EBIT VS OCF VS FCFPMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of PMI (-202.83%) is worse than 90.43% of its industry peers.
Industry RankSector Rank
ROA -202.83%
ROE N/A
ROIC N/A
ROA(3y)-145.47%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PMI Yearly ROA, ROE, ROICPMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 200 400

1.3 Margins

PMI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PMI Yearly Profit, Operating, Gross MarginsPMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -100 -200 -300 -400 -500

More info and screens

0

2. Health

2.1 Basic Checks

PMI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PMI has about the same amount of shares outstanding.
Compared to 1 year ago, PMI has a worse debt to assets ratio.
PMI Yearly Shares OutstandingPMI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M
PMI Yearly Total Debt VS Total AssetsPMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

PMI has an Altman-Z score of -12.60. This is a bad value and indicates that PMI is not financially healthy and even has some risk of bankruptcy.
PMI has a Altman-Z score of -12.60. This is amonst the worse of the industry: PMI underperforms 80.85% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.6
ROIC/WACCN/A
WACC7.92%
PMI Yearly LT Debt VS Equity VS FCFPMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

PMI has a Current Ratio of 0.21. This is a bad value and indicates that PMI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of PMI (0.21) is worse than 96.28% of its industry peers.
A Quick Ratio of 0.06 indicates that PMI may have some problems paying its short term obligations.
With a Quick ratio value of 0.06, PMI is not doing good in the industry: 97.34% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.06
PMI Yearly Current Assets VS Current LiabilitesPMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for PMI have decreased strongly by -31.86% in the last year.
PMI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.93%.
EPS 1Y (TTM)-31.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-12.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PMI Yearly Revenue VS EstimatesPMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PMI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PMI Price Earnings VS Forward Price EarningsPMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PMI Per share dataPMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PMI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PICARD MEDICAL INC

NYSEARCA:PMI (11/28/2025, 7:55:19 PM)

After market: 2.11 -0.02 (-0.94%)

2.13

+0.04 (+1.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap156.98M
Revenue(TTM)4.39M
Net Income(TTM)-23.74M
AnalystsN/A
Price TargetN/A
Short Float %3.09%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 35.75
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.06
BVpS-0.46
TBVpS-0.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -202.83%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-145.47%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.06
Altman-Z -12.6
F-ScoreN/A
WACC7.92%
ROIC/WACCN/A
Cap/Depr(3y)2.17%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.28%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-11.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.66%
OCF growth 3YN/A
OCF growth 5YN/A

PICARD MEDICAL INC / PMI FAQ

What is the fundamental rating for PMI stock?

ChartMill assigns a fundamental rating of 0 / 10 to PMI.


What is the valuation status of PICARD MEDICAL INC (PMI) stock?

ChartMill assigns a valuation rating of 0 / 10 to PICARD MEDICAL INC (PMI). This can be considered as Overvalued.


How profitable is PICARD MEDICAL INC (PMI) stock?

PICARD MEDICAL INC (PMI) has a profitability rating of 0 / 10.